نتایج جستجو برای: hbsag variants

تعداد نتایج: 113345  

Journal: :Chinese medical journal 2016
Xia-Xia Zhang Min-Ran Li Hong-Li Xi Ying Cao Ren-Wen Zhang Yu Zhang Xiao-Yuan Xu

BACKGROUND The ultimate goal of hepatitis B treatment is hepatitis B surface antigen (HBsAg) seroclearance. Several factors have been suggested to be associated with the rate of HBsAg reduction in antiviral-naive or lamivudine therapy cohorts. However, there are few studies evaluating the factors during long-term entecavir (ETV) therapy. In the present study, we aimed to evaluate the factors to...

2016
Reza Rezaee Mansour Poorebrahim Saeideh Najafi Solmaz Sadeghi Alieh Pourdast Seyed Moayed Alavian Seyed Ehsan Alavian Vahdat Poortahmasebi

BACKGROUND Vaccine-escaped hepatitis B virus (HBV) mutations occur within the "a" determinant area, which is located in the major hydrophilic region (MHR) of the hepatitis B surface antigen (HBsAg) protein. It is now well established that the common G145R mutation is highly capable of escaping from HBsAg immune recognition. However, the impacts of this mutation on the structure and immunogenic ...

Journal: :Antiviral therapy 2010
Sheikh Mohammad Fazle Akbar Osamu Yoshida Shiyi Chen Aguilar Julio Cesar Masanori Abe Bunzo Matsuura Yoichi Hiasa Morikazu Onji

BACKGROUND Commercially available prophylactic vaccines containing hepatitis B surface antigen (HBsAg), which are used to prevent HBV infections, are not as effective as a therapeutic immune modulator for treating patients with chronic hepatitis B (CHB). In this study, the immunogenicity of dendritic cells (DC) loaded with both HBsAg and hepatitis B core antigen (HBcAg) was tested in HBV transg...

Journal: :Hepatology 2011
Yun-Fan Liaw

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline during the natural course of a chronic HBV infection; they are lowest in the inactive phase, which is ...

Journal: :Infection and immunity 1975
G R Irwin A M Allen W H Bancroft J J Karwacki H L Brown R H Pinkerton M Willhight F H Top

A survey of hepatitis B patients, asymptomatic hepatitis B antigen (HBsAg) carriers, and control subjects was conducted to determine the relationship between antigenemia and antigen excretion in saliva, urine, and stool. Radioimmunoassay was used to detect HBsAg. Specificity-confirmed HBsAg was detected in the saliva of 6 (30%) of 20 antigenemic patients, 1 (5%) of 20 nonantigenemic patients, 1...

Journal: :Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2006
Geraldine Kaminski Adel Alnaqdy Intesar Al-Belushi Jameel Nograles Said H Al-Dhahry

OBJECTIVES The aim of this study was to determine the prevalence of hepatitis B surface antigen (HBsAg), hepatitis B core antibodies (anti-HBc) and hepatitis B virus (HBV) DNA among a selected group of Omani blood donors. MATERIALS AND METHODS Two hundred HBsAg-negative donors were screened for anti-HBc. Those found to be positive were investigated for HBV DNA by polymerase chain reaction. HB...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1977
W T London J S Drew

Patients undergoing treatment at a community-based renal dialysis clinic were monitored monthly for hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs). Of 160 patients who began treatment HBsAg(-)/anti-HBs(-), 77 subsequently became HBsAg(+). Once HBsAg(+), males were more likely to remain HBsAg(+) indefinitely, whereas females were more likely to convert to HBsAg(-) and devel...

Journal: :Antiviral research 2012
Valentina Svicher Valeria Cento Martina Bernassola Maria Neumann-Fraune Formijn Van Hemert Mengjie Chen Romina Salpini Chang Liu Roberta Longo Michela Visca Sara Romano Valeria Micheli Ada Bertoli Caterina Gori Francesca Ceccherini-Silberstein Cesare Sarrecchia Massimo Andreoni Mario Angelico Antonella Ursitti Alberto Spanò Jing Maria Zhang Jens Verheyen Giuseppina Cappiello Carlo Federico Perno

Occult HBV infection (OBI) is a threat for the safety of blood-supply, and has been associated with the onset of HBV-related hepatocellular carcinoma and lymphomagenesis. Nevertheless, genetic markers in HBsAg (particularly in D-genotype, the most common in Europe) significantly associated with OBI in vivo are missing. Thus, the goal of this study is to define: (i) prevalence and clinical profi...

2017
Chao-Wei Hsu Kung-Hao Liang Chih-Lang Lin Tong-Hong Wang Chau-Ting Yeh

BACKGROUND The concentrations of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) are two critical virological variables to be monitored in chronic hepatitis B. HBsAg is derived from the HBV genome. Thus, higher HBV-DNA concentrations should implicate higher HBsAg levels. Nevertheless, the two variables do not manifest a simple linear relationship due to elusive host factor involvements....

2013
Lei Xu Zhen Yu Wen Fan Xueping Wang Mingshui Xie Yiting Xu Lihua Hu Yirong Li

BACKGROUND RF(Rheumatoid factor) is usually thought to cause positive interference in immunoassay. Recently, our study showed that high-concentration RFs caused negative interference as well as positive interference in serum HBsAg(Hepatitis B surface antigen) ELISA(Enzyme-linked immunosorbent assay), but it is unclear that RF causing negative interference is an anomaly produced by a certain ELI...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید